Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02600611
Brief Title: Phase 3 Study to Evaluate Safety and Efficacy of Iclaprim Versus Vancomycin for ABSSSI: REVIVE-1 (REVIVE-1)

First Submitted : November 5, 2015
First Submitted that Met QC Criteria : November 6, 2015
First Posted : November 9, 2015 (Estimate)

Results First Submitted : March 20, 2018
Results First Submitted that Met QC Criteria : May 19, 2018
Results First Posted : June 19, 2018

Last Update Submitted that Met QC Criteria : May 19, 2018
Last Update Posted : June 19, 2018